enGene Therapeutics ENGN
NASDAQ ENGN
$1.82 -0.03 (-1.62%)
As of: Sep 10, 2026 · 11:38 AM EDT

enGene Therapeutics (ENGN) Exchange Rate Effect (2023 - 2026)

enGene Therapeutics (ENGN) posted Exchange Rate Effect of $1000.0 for Q1 2026, little changed quarter-over-quarter from $1000.0 in Q1 2025, and little changed YoY from $1000.0 in Q1 2025.

Analysis

enGene Therapeutics (ENGN) Exchange Rate Effect (2023 - 2026) Analysis & Trends

enGene Therapeutics (ENGN) has 4 years of Exchange Rate Effect data on file, last reported at $1000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Exchange Rate Effect changed 0.0% year-over-year to $1000.0; the trailing twelve-month figure through Jul 2026 stood at $1000.0 (changed 0.0% YoY), and the FY2025 full-year result was $1000.0, changed 0.0% from the prior year.
  • Exchange Rate Effect was $1000.0 for Q1 2026 at enGene Therapeutics, roughly flat from $1000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1000.0 in Q1 2023 to a low of $1000.0 in Q1 2023.
  • A 4-year average of $1000.0 and a median of $1000.0 in 2023 frame the typical range for Exchange Rate Effect.
  • The largest YoY upside for Exchange Rate Effect was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • enGene Therapeutics' Exchange Rate Effect stood at $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025, then changed by 0.0% to $1000.0 in 2026.
  • Per Business Quant data, the three most recent Exchange Rate Effect figures were $1000.0 in Q1 2026, $1000.0 in Q1 2025, and $1000.0 in Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Krystal Biotech 10.31 Bn 9.47 Bn 112.79 Mn -1.83 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 6,000.00
3 Iovance Biotherapeutics 3.67 Bn 3.37 Bn 55.72 Mn -124,000.00
4 Legend Biotech 3.57 Bn 2.60 Bn 251.50 Mn -300,000.00
5 uniQure 3.01 Bn 3.01 Bn 5.49 Mn -774,000.00
6 Beam Therapeutics 2.55 Bn 2.55 Bn - -
7 Precigen 2.36 Bn 2.36 Bn 52.17 Mn 1,000.00
8 Sarepta Therapeutics 2.17 Bn 1.37 Bn 251.87 Mn -
9 Vericel 1.96 Bn 1.80 Bn 56.40 Mn -
10 enGene Therapeutics 126.92 Mn 126.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2026 1,000.00
Jan 31, 2025 1,000.00
Jan 31, 2024 1,000.00
Jan 31, 2023 1,000.00